Mooranian, A. (2022) “In Vitro Assessments of Microencapsulated Viable Cells as a Result of Primary Bile Acid-Encapsulated Formulation for Inflammatory Disorders”, Scripta Medica, 53(2), pp. 103–115. doi:10.5937/scriptamed53-36574.